FRI0283 Quality Indicators for Use of Biologic Agents in Rheumatic Diseases
Volume: 73, Issue: Suppl 2, Pages: 486.2 - 486
Published: Jun 1, 2014
Abstract
Background
Biologics are widely used for the treatment of rheumatic diseases because of the efficacy, but careful surveillance and prophylactic measures are necessary to reduce the incidence of adverse events, especially infections. Quality indicator (QI) has been received an increasing attention in rheumatology field and several guidelines for the prevention of biologic agents-related infections have been published. However, few...Paper Details
Title
FRI0283 Quality Indicators for Use of Biologic Agents in Rheumatic Diseases
Published Date
Jun 1, 2014
Volume
73
Issue
Suppl 2
Pages
486.2 - 486
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History